ARCHIVES

In Brief: Livingston Completes Term On NCI Board, Appelbaum To Succeed Him as Chairman

This article is from The Cancer Letter archive.

Vol. 25 No. 43 | November 12, 1999

Download PDF Visit The Full Archive

Related Articles

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Study Finds High-Risk Women Reluctant To Take Tamoxifen

December 25, 2009

Also STAR trial can be completed with fewer women than planned, NSABP says.

November 7, 2003

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

NCI advisors approve $144 million program for nanotechnology centers, R01 grants, training. Three to five consortia envisioned.

July 16, 2004